ATH-1105 is a small molecule candidate designed to reduce inflammation and promote neuron growth and survival, slowing ...
The risk of death was nearly 60% lower in ALS patients given the experimental oral therapy CNM-Au8 than for an external ...
Financial planning can help with managing expenses related to living with ALS so you can focus on your health and well-being.
Early ALS intervention with medication and therapy is critical for slowing disease progression and making it easier to manage ...
COYA 302, an experimental combination immune-modulating therapy, safely slowed disease progression in four ALS patients in a ...
ALS Northwest and the Oregon State Treasury established a college scholarship program for students who have lost parents or ...
Columnist Juliet Taylor worries about all the ALS caregivers and their charges when the inevitable illnesses and accidents ...
In the agreement, Eli Lilly will develop QRL-204 and other UNC13A-targeting compounds and will work with QurAlis to identify ...
Tiziana applied for an ALS Association grant to fund an early-stage clinical trial of intranasal foralumab to treat ALS.
There's been an evolution in understanding ALS progression and the diversity of patients, columnist Dagmar Munn writes.
Adding Radicava to riluzole prolongs survival of amyotrophic lateral sclerosis patients by more than three months relative to riluzole alone.
Columnist Dagmar Munn is thrilled to see ALS portrayed accurately in the film "New Life." Disability representation is improving, she says.